AIDS By The Numbers in Oromia 2022

People newly infected with HIV
People living with HIV
People died of AIDS
0 %
Prevalence rate

AIDS By The Number in Ethiopia 2022

People newly infected with HIV
People living with HIV
People died of AIDS
0 %
HIV Prevalence rate

Latest News

July 17, 2023
Researchers solve structure of immune-evading HIV protein complex

The HIV-1 virus can neutralize cellular defenses with its viral infectivity factor (Vif). OIST researchers Prof. Matthias Wolf and Dr. Takahide Kouno together with an international team of colleagues have now determined the atomic structure of the APOBEC3G-Vif complex using cryo-electron microscopy. “APOBEC3G (A3G) is a key component of the human innate immune system to defend against invading viruses, getting a ride inside budding virions like in a Trojan horse so that it can modify and disable viral DNA after reverse transcription in infected cells,” explains Prof. Wolf, the senior author of the study and who leads the OIST Molecular Cryo-Electron Microscopy Unit.

17 May 2023
The Oromia Health Bureau is conducting a public awareness program on HIV/AIDS prevention and control.

The purpose of this program is to showcase the current state of the HIV/AIDS epidemic and raise awareness on the precautions to be taken.

According to the director of the HIV/AIDS prevention and control directorate of the Oromia Health Bureau, Dr. Tesfaye Zerfu, there are currently more than 151,000 HIV positive people in the state, of whom 127,592 have been tested positive for the virus and 123,663 are on antiretroviral therapy started taking antiretroviral therapy, and 96.4% of those who started taking antiretroviral therapy mentioned that the virus had dropped in their blood.

27 March 2023

To Prevent and Control Cholera

In collaboration with Oromia Broadcasting Network, the Oromia Health Bureau conducted a panel discussion on how to prevent and control the recent cholera endemic/ epidemic in certain part of the region.

20 March 2023

Top 5 stories on new drugs for HIV prevention and treatment from CROI 2023

At the Conference on Retroviruses and Opportunistic Infections (CROI 2023) in February, many researchers presented studies looking at new drugs being tested for use as treatment, pre-exposure prophylaxis (PrEP), and post-exposure prophylaxis (PEP). Here are some highlights.

Lenacapavir given alongside broadly neutralising antibodies (bnAbs) may offer a twice-yearly treatment option. In this new study, 90% of people who received injections of lenacapavir (Sunlenca) plus infusions of two long-acting bnAbs had an undetectable viral load six months after stopping their existing antiretroviral therapy


March 15, 2023

Every 1-year increase in partner age linked to a 9% greater likelihood of HIV acquisition among young women in Africa

While male sexual partners in the 35 to 44 age band confer the greatest HIV risk for adolescent girls and young women, men aged 25 to 34 years drive the majority of new HIV acquisitions as most young women have partners in this age band, a study from eight African countries has concluded.

The study, published in the journal AIDS, further reveals that each one-year increase in partner age is associated with a 9% greater likelihood of recent HIV acquisition among females between 15 and 24 years.

20 February 2023

Third person cured of HIV after stem cell transplant, researchers say

The patient in Germany was given the transplant to help treat a blood disorder, which in his case was leukaemia that had developed alongside his HIV infection and after four years of not taking anti-retroviral medicine, he has not relapsed. Similar to the other two stem cell transplant patients – one in Berlin and another in London – the man, in Dusseldorf, had the transplant to treat a blood disorder, which in his case was leukaemia, which had developed alongside the HIV infection.


African leaders unite in pledge to end AIDS in children

DAR ES SALAAM, 1 February 2023—Ministers and representatives from twelve African countries have committed themselves, and laid out their plans, to end AIDS in children by 2030. International partners have set out how they would support countries in delivering on those plans, which were issued at the first ministerial meeting of the Global Alliance to end AIDS in children

5 December 2022

In collaboration with Adama City Health office, East Shewa Health Office, East Shewa Education Office, Adama City Health Office, Adama District Health Offfice, and Adama District Education Office, the Adama HIV/AIDS Resource center organized a half day training for the high schools’ anti-HIV/AIDS clubs coordinators from Adama City, and Adama district on Sadaasa 24/2015 [ 3 December 2022]

The training was about how the anti-HIV/AIDS club coordinators provide SDI services ( Selective Dissemination of Information) to students via schools’ mini medias; and of course about peer education.




The Adama HIV/AIDS Resource Center published two kinds of IEC/BCC materials for students in schools.  A poster  and brochure, which are of great benefit in raising awareness about HIV/AIDS, and other related issues in schools.


This 1st phase of audio-HIV/AIDS messages were complied for students/young population in the schools, which are intended to be transmitted every week via their respective mini media during break times.

Most of the messages were taken from the resource book entitled “ የትምህርት ቤቶች ሚኒ ሚዲያ እና የፀረ ኤድስ ክበብ የኤች አይቪ/ኤድስ አጋዥ መረጃ ___ በትምህርት ሚኒስቴር እና ኤች አይቪ/ኤድስ መከላከያ እና መቆጣጠሪያ ፅ/ቤት የተዘጋጀ”.

What the Adama HIV/AIDS Resource Center has done:

  • Translating to Afan Oromo, and changing the text format of the message into audio in Afan Oromo and Amharic provided that they can be enabled to be transmitted through schools’ mini media.
  • Transmitting the messages as SDI services (Selective Dissemination of Information) to students in schools, i.e. transmitting a selected message [among many] at a time for some target group of society.

Please be informed that the services have been already in progress in most schools in East Shewa.



October 21, 2022

Early HIV diagnosis and treatment important for better long-term health outcomes


Starting antiretroviral treatment (ART) early in the course of HIV infection when the immune system is stronger results in better long-term health outcomes compared with delaying ART, according to findings presented today at the IDWeek Conference in Washington, D.C.


Full report — In Danger: UNAIDS Global AIDS Update 2022

10 August 2022

New data from UNAIDS on the global HIV response reveals that during the last two years of COVID-19 and other global crises, progress against the HIV pandemic has faltered, resources have shrunk, and millions of lives are at risk as a result.

Progress in prevention and treatment is faltering around the world, putting millions of people in grave danger. Eastern Europe and central Asia, Latin America, and the Middle East and North Africa have all seen increases in annual HIV infections over several years.

Download Report:  In Danger: UNAIDS Global AIDS Update 2022

New global alliance launched to end AIDS in children by 2030

2 August 2022

Globally, only half (52%) of children living with HIV are on life-saving treatment, far behind adults where three quarters (76%) are receiving antiretrovirals, according to the data that has just been released in the UNAIDS Global AIDS Update 2022. Concerned by the stalling of progress for children, and the widening gap between children and adults, UNAIDS, UNICEF, WHO and partners have brought together a global alliance to ensure that no child living with HIV is denied treatment by the end of the decade and to prevent new infant HIV infections.

Monkeypox is an illness caused by the monkeypox virus. It is a viral zoonotic infection, meaning that it can spread from animals to humans. It can also spread from person to person.

Monkeypox can cause a range of signs and symptoms.  While some people have mild symptoms, others may develop more serious symptoms and need care in a health facility. Those at higher risk for severe disease or complications include people who are pregnant, children and persons that are immunocompromised.

The most common symptoms of monkeypox include fever, headache, muscle aches, back pain, low energy, and swollen lymph nodes. Symptoms typically last two to three weeks and usually go away on their own or with supportive care, such as medication for pain or fever. People remain infectious until all of the lesions have crusted over, the scabs fallen off and a new layer of skin has formed underneath.

The Oromia Health Bureau announced it will undertake the3rd campaign of COVID-19 Vaccination for the people aged 12 years and above starting from  june 10 /06/2022  (Waxabajii 2, 2014 E.C)



In collaboration with Adama City Education Office, and Health Offcie, the Adama HIV/AIDS Resource Center conducted training for the coodinators of anti-HIV/AIDS clubs of high schools in Adama on 21  May 2022. The pupose of the training was indeed to strengthen their respective anti-HIV/AIDS clubs so that they can undertake the desire HIV awareness activites in their schools.




Key considerations to integrate HIV and mental health interventions

new publication by UNAIDS and the World Health Organization (WHO) emphasizes the importance of integrating HIV and mental health services and other interventions, including linkages to social protection services, for people living with HIV and other vulnerable populations.

Mental health conditions increase the risk of HIV infection, and people living with HIV have an increased risk of mental health conditions, which are associated with lower retention in HIV care, increased risk behaviours and lower engagement with HIV prevention.




First case of HIV cure in a woman after stem cell transplantation reported at CROI-2022 

The International Maternal Pediatric Adolescent AIDS Clinical Trial Network (IMPAACT) P1107 reported the first case of HIV cure in a woman living with HIV submitted to a dual stem cell transplant (i.e., an umbilical cord blood transplant combined with a half-matched bone marrow transplant) for treatment of an acute myelogenous leukemia. The IMPAACT P1107 researchers presented the case details during the oral abstract session held at the 29th Conference on Retroviruses and Opportunistic Infections (CROI 2022). The study participant is a woman from New York (USA) who stopped antiretroviral therapy (ART) at 37 months post-transplant and has had no HIV detected for 14 months. The dual stem cell therapy also led to remission from leukemia that she developed in 2017.



 Women and Girls Carry the Heaviest HIV Burden In Sub-Sahara Africa

Gender inequality and discrimination robs women and girls of their fundamental human rights, including the right to education, health and economic opportunities. The resulting disempowerment also denies women girls sexual autonomy, decision making power, dignity and safety.




In collaboration with Adama City Health Office and East Shewa Health Office,  the Adama HIV/AIDS Resource Center conducted a HIV awareness campaign at East Shewa Prison on  15 March 2022. About 300 inmates were given desirable awareness on why they are most vulnerable, and how they can protect themselves from HIV infections. Voluntary, Counseling and Testing (VCT) was undertaken for some of the prisoners.






The HIV/AIDS Club members of Gadaa Michilee School of Adama visited  the Adama HIV/AIDS Resource Center on 29 March 2022. The management of the resource center welcomed and gave them necessary orientations on the goals and services of the center.





Provide up-to-date and accurate information on HIV/AIDS, STDs, and Tb, developing and distributing culturally appropriate behavior change communication materials, and gathering and distributing resource materials from other sources.


Provide researchers, policy makers, health providers, media professionals and the general public with access to high-tech Internet connection to conduct research on current health issues.


Provide informational resources support to the projects and activities of the regional HAPCO and Health Bureau in HIV/AIDS, STDs, and TB.


Provide broadcast media with local perspectives and information on regional HIV/AIDS issues


HIV/AIDS in Ethiopia

Frequently Asked Questions About HIV/AIDS

HIV is the virus that causes AIDS. Most people who have HIV have no symptoms at all, but can still give the virus to other people. On average, it can take ten years for someone who has HIV to develop AIDS. AIDS is a serious condition in which the body’s ability to resist getting sick is seriously weakened. Once a person  develops AIDS, mild diseases like colds and flu can lead to death. A person with AIDS is also very likely to get other, less common diseases like tuberculosis that most healthy people don’t get very easily.

HIV is the virus that causes AIDS. Most people who have HIV have no symptoms at all, but can still give the virus to other people. On average, it can take ten years for someone who has HIV to develop AIDS. AIDS is a serious condition in which the body’s ability to resist getting sick is seriously weakened. Once a person  develops AIDS, mild diseases like colds and flu can lead to death. A person with AIDS is also very likely to get other, less common diseases like tuberculosis that most healthy people don’t get very easily.

 No. This is because HIV is not an airborne, water-borne or food-borne virus. HIV can be passed from one person to another only when people exchange blood or sexual fluids (like semen or vaginal secretions). HIV cannot survive for very long outside of the human body. So you can’t get HIV by having ordinary social contact with an infected person.

These are the main ways in which someone can become infected with HIV:

  • Having vaginal or anal sex without a condom with someone who is infected.
  • Having contact with the blood of someone who has HIV. This could be having a blood transfusion from someone who is infected with HIV
  • From a mother who has HIV to her baby: HIV can pass to the baby during pregnancy, during the birth of the baby, or through breast-feeding. Only about one in three babies born to HIV-positive mothers get HIV.
  • Receiving an injection from an unsterilized needle that was previously used by someone with HIV.


  •  No. Infection with HIV has no specific symptoms. The only way you can find out if you are infected with HIV is by  having an HIV test, a test that looks for antibodies to HIV in your blood. Antibodies are made by your body to try to fight infection. But usually, it takes about 3 months after HIV infection for people to develop antibodies to HIV.
  • Getting an HIV test before the 3-month period is up can result in an unclear test result, because an infected person may not yet have developed antibodies to HIV. It is best to wait at least three months after the last time you could have been exposed to HIV (i.e., having sex without a condom or having an injection from a needle that could have been contaminated) before taking the test. Even if your test is negative after 3 months, some test centers may recommend testing again at 6 months, just to be extra sure.
  • It is also important that you take precautions not to further expose yourself to HIV if you have been exposed and are waiting to have the HIV test. If you are sexually active, you should use a condom every time you have sex, and you should be careful to avoid contact with other people’s blood and needles that could be contaminated.
  •  HIV tests don’t take very long. The test involves taking a small sample of blood, which is analyzed for the presence of HIV antibodies. Depending on the kind of test used by the center you go to, you can get your test result in a few minutes.
  • I want to find out whether I could have HIV, but first, I want to be able to ask an expert questions about HIV and the HIV test. I’m also scared the test could be positive, and want to be able to talk through the results with someone who can help me understand what they mean. What should I do?
  • You may want to consider voluntary counseling and testing (VCT). VCT is a process of receiving counseling before and after an HIV test to help you prepare for the test and help you understand your test results. A trained counselor who knows about HIV and AIDS, and understands the stress you might be feeling about not knowing whether you are infected with HIV. The counselor can also help you understand your test results. If your test is negative, the counselor can help you decide ways to reduce your risk of becoming infected with HIV in the future. If your test is positive, the counselor can help you understand what being HIV-positive means, and help you learn ways to stay healthy for a long time. The counselor can also help you identify ways to avoid infecting other people with HIV, and sources
    of support for you.  

 A positive result means:

  • You are HIV-positive, meaning the virus that eventually leads to AIDS was found in your body.
  • Being HIV-positive means that you could infect others with HIV if you have unprotected sex.
  • Finding out you are HIV-positive can be a traumatic experience. Many people worry about what their families, friends, and community will think. Talking to a counselor can help.
  • A positive result does NOT mean:
  • You have AIDS.
  • You will die soon. People who take good care of their bodies by eating nutritious food, maintaining good hygiene, and avoiding contact with those who are sick can live for many years with HIV.
  • A negative result means:
  • No antibodies were found in your blood at this time.
  • A negative result does NOT mean:
  • You are not infected with HIV (if you could have been exposed to HIV at any time in the last 3-6 months)
  • You are immune to AIDS or will never get AIDS.
  •  Yes. A pregnant woman can pass HIV/AIDS to her baby while she is pregnant or during the birth of the baby. A mother can also pass HIV/AIDS on to her baby through breastfeeding (there are small amounts of HIV in the breast milk of HIV-infected women). About one out of three babies born to HIV-positive mothers in Ethiopia get HIV/AIDS in one of these ways.
  • If a woman is HIV-positive, there are several ways to reduce the likelihood she will pass the HIV infection on to her baby. A doctor might give her drugs such as zidovudine (AZT) and nevirapine (if they are available) to a pregnant woman with HIV/AIDS to decrease her chance of passing the infection to her baby. Good nutrition and antenatal care can also reduce this risk. An HIV-positive woman may wish to talk to a counselor or doctor about the advantages and disadvantages of breastfeeding her baby.
  • Testing pregnant women for HIV is not routine in Ethiopia .However, if a woman knows whether or not she is HIVpositive, she can make careful decisions to protect the health of her child if she is pregnant or plans to become pregnant. 

 Throughout recorded history, mosquitoes and other arthropods have been responsible for spreading many epidemics. Plague was spread by fleas, typhus by lice, and malaria by mosquito. For malaria and yellow fever, the respective parasites (a protozoan and a virus) multiply in the mosquito, and then concentrate in its salivary gland. When the mosquito takes its next blood meal, the parasites pass with its saliva into the victim’s blood. No such model exists for AIDS. It should also be noted that mosquitoes suck blood; they do not inject blood from one person into another. Additional evidence that no animal intermediate is involved in HIV transmission comes from Africa . It is well known that African children play outside in mosquito infested areas. Children would constitute a large percentage
of African AIDS cases if the disease were mosquito-borne. Statistics show, however, that children represent a relatively small percentage of Africans with AIDS. Many African children suffer from malaria, but comparatively few suffer from AIDS. Scientists have shown that HIV can remain active within mosquitoes for a period of several hours after they have been fed blood with a high concentration of the virus. This observation, however, does not support the notion that mosquitoes transmit HIV in nature because the virus neither multiplies within a mosquito nor concentrates at a point where it can leave the mosquito. 

About Us

Oromia AIDS Resource Center (OARC) which is found in Adama city is the center which is established for the provision of different IEC/BCC resources materials on Reproductive Health, HIV/AIDS Sexually Transmitted Diseases (STDs), and Tuberculosis (TB).